SCHEMBL4012485

SCHEMBL4012485

COC(=O)c1cc(C(O)CNC(C)(C)CCN2C=CN(c3ccc(OC)cc3)C2)ccc1OCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 5/20 0.39
ADRB2 P07550 3/20 0.39
ADRB1 P08588 3/20 0.39
LRRK2 Q5S007 1/20 0.36
APP P05067 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
KMT2A Q03164 1/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
CASR P41180 1/20 0.35
F2 P00734 1/20 0.35
F7 P08709 1/20 0.35
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4013458 0.88 ADRB2 (0.42) ADRB2ADRB1CASRMTNR1AMTNR1B
SCHEMBL11748288 0.82 ADRB2 (0.49) ADRB3ADRB2ADRB1ADRA1DADRA1A
SCHEMBL4016606 0.80 ADRB3 (0.37) ADRB3ADRB2ADRB1LRRK2APP
SCHEMBL4013270 0.79 PPARG (0.37) ADRB3ADRB2ADRB1LRRK2CYP2C9
SCHEMBL4012862 0.78 ADRB2 (0.41) ADRB3ADRB2ADRB1LRRK2KMT2A
SCHEMBL4670569 0.76 ADRB2 (0.48) ADRB3ADRB2ADRB1KMT2AF2
SCHEMBL14080472 0.76 ADRB2 (0.48) ADRB3ADRB2ADRB1KMT2AF2
SCHEMBL14080487 0.76 ADRB2 (0.48) ADRB3ADRB2ADRB1KMT2AF2
SCHEMBL4012539 0.76 ADRB2 (0.49) ADRB3ADRB2ADRB1CYP1A2
Cadaverine Tartrate SCHEMBL14080565 0.73 F2 (0.46) ADRB3ADRB2ADRB1KMT2AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511067-B2 3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-31 US disclosed
US-20080132556-A1 3-HYDROXYMETHYL-4HYDROXY-PHENYL- DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES BOUYSSOU THIERRY 2008-06-05 US disclosed
US-20050234112-A1 3-Hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234112-A1 3-Hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases PAH, CYP11B1, CYP11B2 ADRB3 44/4885ADRB2 117/4885ADRB1 69/4885
US-20080132556-A1 3-HYDROXYMETHYL-4HYDROXY-PHENYL- DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES PAH, CYP1A1, CYP11B1 ADRB3 110/4885ADRB2 169/4885ADRB1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.